HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$1.50
Day range
$1.45 - $1.51
Year range
$1.12 - $8.40
Market cap
46.81M USD
Avg Volume
6.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.07M | 243.84% |
Net income | -5.07M | -249.89% |
Net profit margin | — | — |
Earnings per share | -0.17 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 754.32K | -59.96% |
Total assets | 829.61K | -60.53% |
Total liabilities | 348.39K | -34.78% |
Total equity | 481.22K | — |
Shares outstanding | 32.28M | — |
Price to book | 75.00 | — |
Return on assets | -1,919.26% | — |
Return on capital | -5,000.11% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -5.07M | -249.89% |
Cash from operations | -696.44K | 54.27% |
Cash from investing | — | — |
Cash from financing | 1.05M | 691.14% |
Net change in cash | 351.32K | 125.27% |
Free cash flow | -3.46M | -247.65% |
About
Founded
2021
Headquarters
Website
Employees
5